PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
Hypoglycemia		Disease	Target	CAMK2D
Diabetes		Disease	Target	CAMK1D
Prostate Cancer		Disease	Target	Alpha Platelet-Derived Growth Factor Receptor
Inflammatory Bowel Disease		Disease	Target	Protein Fimh
Hearing Loss		Disease	Target	CAMK2B
Ovarian Cancer		Disease	Target	AMY2B
Ovarian Cancer		Disease	Target	CAMK2D
Brain Injury		Disease	Target	CAMK2D
Seizure		Disease	Target	CAMK2D
Arthritis		Disease	Drug	Alefacept (Amevive)- FDA
Arthritis		Disease	Drug	Amevive (Alefacept)- FDA
Shock		Disease	Target	DJ-1/PARK7
Influenza		Disease	Target	CAMK2B
Influenza		Disease	Target	Protein Fimh
Obesity		Disease	Target	CAMK1D
Obesity		Disease	Target	CAMK2D
Obesity		Disease	Target	AMY2B
Stroke		Disease	Target	CAMK1D
Stroke		Disease	Target	CAMK2D
Infection		Disease	Target	Protein Fimh
Diabetes		Disease	Target	AMY2B
Cholesterol		Disease	Target	CAMK2B
Depression		Disease	Target	CAMK2D
Depression		Disease	Target	CAMK2B
Inflammation		Disease	Target	Protein Fimh
Cancer		Disease	Target	DJ-1/PARK7
Diabetes		Disease	Drug	Alefacept (Amevive)- FDA
Diabetes		Disease	Drug	Amevive (Alefacept)- FDA
Cancer		Disease	Target	AMY2B
Cancer		Disease	Target	CAMK2B
Cancer		Disease	Target	Alpha Platelet-Derived Growth Factor Receptor
Carcinoma		Disease	Target	AMY2B
Carcinoma		Disease	Target	CAMK1D
Carcinoma		Disease	Target	DJ-1/PARK7
Cancer		Disease	Target	CAMK1D
Cancer		Disease	Target	CAMK2D
Infection		Disease	Target	CAMK2D
Cancer		Disease	Drug	Alefacept (Amevive)- FDA
Cancer		Disease	Drug	Amevive (Alefacept)- FDA
Myelodysplastic Syndrome		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Acute Promyelocytic Leukemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Diabetic Nephropathy		Disease	Drug	Dracorhodin
Psychiatric Disorder		Disease	Target	Cyclooxygenase-3
Graft Versus Host Disease		Disease	Target	4-1BB Receptor
Anemia		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Scars		Disease	Drug	Dracorhodin
Arrhythmia		Disease	Drug	Apresoline (Hydralazine)- FDA
Syphilis		Disease	Drug	Apresoline (Hydralazine)- FDA
Glomerulonephritis		Disease	Drug	Apresoline (Hydralazine)- FDA
Prostate Cancer		Disease	Drug	Dracorhodin
Renal Failure		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Anemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Hemorrhage		Disease	Drug	Apresoline (Hydralazine)- FDA
Obesity		Disease	Target	BRSK1
Carcinoma		Disease	Target	4-1BB Receptor
Stroke		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Cancer		Disease	Target	BRSK1
Hepatitis		Disease	Drug	Apresoline (Hydralazine)- FDA
Breast Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Cholesterol		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Cancer		Disease	Target	4-1BB Receptor
Diabetes		Disease	Target	BRSK1
Cancer		Disease	Drug	Dracorhodin
Infection		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Carcinoma		Disease	Target	BRSK1
Carcinoma		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Cancer		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Brain Cancer		Disease	Target	Kallikrein-8
Acute Promyelocytic Leukemia		Disease	Target	464.1
Ovarian Cancer		Disease	Target	Kallikrein-8
Skin Disease		Disease	Target	Eotaxin-2/CCL24
Nausea		Disease	Drug	Amitiza (Lubiprostone)- FDA
Diarrhea		Disease	Drug	Amitiza (Lubiprostone)- FDA
Metastatic Breast Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Benign Prostatic Hyperplasia		Disease	Target	Kallikrein-8
Graft Versus Host Disease		Disease	Target	AMAC-1
Chronic Pain		Disease	Target	Mu-Type Opioid Receptor
Osteoporosis		Disease	Target	ALK Phos
Dyspnea		Disease	Drug	Amitiza (Lubiprostone)- FDA
Headache		Disease	Drug	Amitiza (Lubiprostone)- FDA
Non Small Cell Lung Cancer		Disease	Target	Kallikrein-8
Colon Cancer		Disease	Target	Complement Decay-Accelerating Factor
Osteoarthritis		Disease	Target	ALK Phos
Osteoarthritis		Disease	Target	Kallikrein-8
Poisoning		Disease	Target	ALK Phos
Prostate Cancer		Disease	Target	464.1
Prostate Cancer		Disease	Target	ALK Phos
Prostate Cancer		Disease	Target	Kallikrein-8
Renal Failure		Disease	Target	464.1
Renal Failure		Disease	Target	ALK Phos
Infection		Disease	Target	Tegument Protein Vp16
Pneumonia		Disease	Target	ALK Phos
Anemia		Disease	Target	ALK Phos
Lung Cancer		Disease	Drug	Kaad-Cyclopamine
Lung Cancer		Disease	Target	Kallikrein-8
Cancer		Disease	Target	Kallikrein-8
Arthritis		Disease	Target	Eotaxin-2/CCL24